SOGROYA

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: fe1cc5df8917268f
Drug Approval Canada Name: SOGROYA
Product Name: SOGROYA
Status: Marketed
Status Date: 2023-11-27
Original Market Date: 2023-11-27
Din: 02539950
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 68:28.00
Atc Original: H01AC07 SOMAPACITAN
Atc Name: h 01 ac 07
Aig Number: 0164861003
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

SOMAPACITAN

15 MG / 1.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fe1cc5df8917268f

Type

Standard